Vitiligo: vizsgálatok itt: India

1 trial · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.

• 2. fázisTaking people
  A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

  Where

  Ahmedabad, Bangalore, Belagavi, Mysore, Nashik, Patna

  Életkor

  18 év to 99 év

  People

  210 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07431177 · EU 2025-522301-37-00